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ABSTRACT
Background and Purpose. In open surgery procedures,
after temporarily dimming the lights in the operation the-
atre, the Photo Dynamic Eye (PDE) fluorescence camera
has, amongst others, been used for fluorescence-guided
sentinel node (SN) biopsy procedures. To improve the
clinical utility and logistics of fluorescence-guided surgery,
we developed and evaluated a prototype modified PDE (m-
PDE) fluorescence camera system.
Methods. The m-PDE works under ambient light condi-
tions and includes a white light mode and a pseudo-green-
colored fluorescence mode (including a gray-scaled
anatomical background). Twenty-seven patients scheduled
for SN biopsy for (head and neck) melanoma (n = 16),
oral cavity (n = 6), or penile (n = 5) cancer were inclu-
ded. The number and location of SNs were determined
following an indocyanine green-99mTc-nanocolloid
injection and preoperative imaging. Intraoperatively, fluo-
rescence guidance was used to visualize the SNs. The m-
PDE and conventional PDE were compared head-to-head
in a phantom study, and in seven patients. In the remaining
20 patients, only the m-PDE was evaluated.
Results. Phantom study: The m-PDE was superior over
the conventional PDE, with a detection sensitivity of
1.20 9 10-11 M (vs. 3.08 9 10-9 M) ICG in human
serum albumin. In the head-to-head clinical comparison
(n = 7), the m-PDE was also superior: (i) SN visualization:
100 versus 81.4 %; (ii) transcutaneous SN visualization:
40.7 versus 22.2 %; and (iii) lymphatic duct visualization:
7.4 versus 0 %. Findings were further underlined in the 20
additionally included patients.
Conclusion. The m-PDE enhanced fluorescence imaging
properties compared with its predecessor, and provides a
next step towards routine integration of real-time fluores-
cence guidance in open surgery.
Different groups have reported that for effective intra-
operative (near-infrared) fluorescence imaging the lights in
the operating room have to be dimmed, or switched off, in
order to visualize the fluorescence signal.1,2 This results in
temporary stalling of the surgical procedure, even when the
fluorescence camera itself is equipped with a white light
source.2 Therefore, in general, the fluorescence guidance
technology is primarily used to provide static confirmatory
information regarding the location of lesions.3 Ideally,
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during a surgical procedure the technique would be used to
allow the surgeon to excise the lesion of interest under real-
time fluorescence guidance.
Previously, in laparoscopic studies using the hybrid tracer
indocyanine green (ICG)–99mTc-nanocolloid, we showed
that the value of real-time fluorescence guidance signifi-
cantly increased when the fluorescent signal was displayed
within the anatomical context of the patient.4 For open sur-
gery procedures, using the Photo Dynamic Eye fluorescence
camera (PDE; Hamamatsu Photonics K.K., Hamamatsu,
Japan), we saw that in some cases the background signal
helped provide anatomical context.5–7 We reasoned that
exploiting this feature further could aid the routine embed-
ment of the technology. Allowing fluorescence guidance
under ambient light conditions would, at the same time, help
simplify clinical logistics. To achieve our goals, we set out to
develop a prototype modified PDE (m-PDE) fluorescence
camera, and evaluated it in both a phantom and patient study.
MATERIALS AND METHODS
Fluorescence Camera Systems
We evaluated the newly developed prototype m-PDE
fluorescence camera and compared it to the commercially
available conventional PDE (c-PDE) fluorescence camera
(Hamamatsu Photonics K.K., Hamamatsu, Japan).
The main differences between the c-PDE and the m-PDE
are shown in Table 1. Briefly, the light-emitting diode (LED)-
based near-infrared excitation light of the c-PDE works in a
continuous wave mode, while the illumination source of the
m-PDE is pulsed in synchronization with the frame rate of the
charge-coupled device (CCD). Here, pulsation means the
CCD detector obtains both a fluorescence image containing
ambient light background signal and an image of the ambient
light background only. Real-time subtraction of the two
images then allows the m-PDE to obtain a ‘pure’ fluorescence
image (in gray-scale or pseudo-green-color) under ambient
light conditions. Second, the m-PDE also allows real-time
mixing of the ‘pure’ pseudo-green-colored fluorescence
image with the gray-scale anatomical context image. As a
third improvement, the m-PDE can also show a white light
image in a non-fluorescence imaging setting.
Phantom Study
A 5.0 mg/mL (6.45 9 10-3 M) ICG (ICG-Pulsion,
25 mg vial; Pulsion Medical Systems, Munich, Germany)-
human serum albumin (HSA; Albuman 200 g/L; Sanquin,
Amsterdam, The Netherlands) solution was prepared and
diluted 1:1 with HSA in 30 steps down to 9.31 ng/mL
(1.20 9 10-11 M). From each dilution 100 lL was
pipetted in a black 96-well plate (Cellstar; Greiner Bio-One
GmbH, Frickenhausen, Germany). The complete dilution
range was then evaluated to determine the detection sen-
sitivity of the m-PDE and c-PDE fluorescence camera
systems. Hereby, the head of the fluorescence cameras was
fixed, perpendicular, at a 14 cm distance from the well-
plate surface. This allowed capture of the whole dilution
range in the field of view.
Imaging of the plate was performed under different set-
tings—white light (m-PDE only) and fluorescence (both
systems) and under various light conditions: (i) all lights in the
operating room turned on (halogen satellite lamps directly
lighting the sterile field [angle of approximately 45 with
regard to the plate surface], the plenum and surrounding lights
[both tubular lights]); (ii) satellite lamps directly lighting the
sterile field turned off, but the plenum and surrounding lights
on (referred to as ‘ambient light’ conditions); and (iii) all lights
in the operating room dimmed. For the m-PDE fluorescence
camera system evaluation, in all experiments the pseudo-
colored green setting was used.
As a reference for the fluorescence intensity measured
with the c-PDE and m-PDE fluorescence camera systems,
the ICG-based dilution range was also measured on pre-
clinical, cooled, black box, camera systems (IVIS
Spectrum, Xenogen Corporation, San Francisco, CA, USA;
and the Pearl Impulse, LI-COR Biotechnology GmbH,
Hombur, Germany). The fluorescence image obtained with
the IVIS Spectrum was presented in a pseudo-colored glow
scale, whereas for the Pearl Impulse, the fluorescence
signal was presented in a pseudo-colored green scale. For
both systems, the fluorescence images were overlaid onto a
black and white background image.
For quantification of the fluorescence signal measured
with the IVIS Spectrum, in the acquired fluorescence
image, regions of interest were drawn surrounding the
wells after which Living Image 3D analysis software
(version 1.0; Xenogen Corporation) was used to quantify
the signal intensity per well.
Light Spectra Measurements
Light spectra of the different lamps present in the
operating room were determined using a Jobin Yvon
VS140 linear array fiber spectrometer (Horiba, Kyoto,
Japan) in the 300–1200 nm range, with an integration time
of 0.1 ms. The fiber was held at a 2-meter distance from the
lamp from which the light spectra were measured.
Absorption and Emission Spectra Measurements of
ICG–HSA
The absorption and emission spectrum of ICG-HSA
(concentration: 1.5 9 10–9 M) was measured using an
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Ultrospec 3000 UV/Vis spectrophotometer (Pharmacia
Biotech/GE Healthcare Europe GmbH, Eindhoven, The
Netherlands) and an LS55 fluorescence spectrometer
(PerkinElmer, Groningen, The Netherlands). Solutions
were prepared in a 3 mL quartz cuvet (Hellma GmbH &
Co. KG, Mu¨llheim, Germany).
Patient Study
Patients Patients with squamous cell carcinoma of the
oral cavity (n = 6) or penis (n = 5), head and neck
melanoma (n = 11), or melanoma on the trunk or on an
extremity (n = 5) scheduled for sentinel node (SN) biopsy
with subsequent treatment of the primary tumor/re-excision
of the melanoma scar were prospectively enrolled after
obtaining written informed consent. All included patients
were clinically node-negative as defined by palpation and
ultrasound-guided fine needle aspiration cytology. Patient
characteristics are shown in Table 2. The study protocol
was conducted in accordance with the Helsinki Declaration
and approved by the Medical Ethical Committee of the
Dutch Cancer Institute – Antoni van Leeuwenhoek
Hospital.
Hybrid Tracer Preparation, Administration,
Preoperative Sentinel Node Mapping and (Histo-)
Pathology
Preparation and administration of the hybrid tracer
ICG–99mTc-nanocolloid, preoperative imaging, and (histo-)
pathological specimen analysis for oral cavity cancer,6
penile cancer,8 and (head and neck) melanoma7 have been
previously described.
Surgical Procedure In patients with head and neck
malignancies, primary tumor removal or re-excision of the
melanoma scar was completed prior to performing SN
biopsy. In penile cancer patients and patients with a
melanoma on the trunk or on an extremity, SN biopsy was
performed prior to treatment of the primary tumor site or
the melanoma scar. A schematic overview of the
intraoperative SN excision procedure is given in Fig. 1.
RESULTS
Phantom Study
Reference Fluorescence Data Figure 2a illustrates the
relation between the ICG–HSA concentration and the
fluorescence intensity measured with the IVIS Spectrum.
Under black-box conditions, the lowest concentration
evaluated (1.20 9 10-11 M ICG–HSA) could be easily
detected using this system (Fig. 2b). The Pearl Impulse
showed a similar detection range (data not shown).
Spectral analysis of the light emissions encountered
for the different light settings evaluated in the operating
room (Fig. 2c) revealed that the light spectrum of the
(halogen) satellite lamps gives a broad emission spectrum
that shows significant overlap with the spectral area
where the ICG emission is collected. The severity with
which the satellite lamps influenced ICG detection
depended on the angle under which the satellite lamp
was placed relative to the phantom. Hereby, the sensi-
tivity for ICG was highest when the satellite lamp was
angled so that the reflected satellite lamplight did not
align with the position of the fluorescence camera. The
normal surrounding lamps (tubular lights) displayed an
assembly of light peaks, with the most pronounced
emission maxima at 545 and 612 nm, which showed a
limited degree of spectral overlap with the emission peak
of ICG (Fig. 2c, d).
TABLE 1 Characteristics of the conventional and modified PDE fluorescence cameras
c-PDE m-PDE
Excitation light source LED (continuous) LED (pulsed)
Imaging device CCD CCD
Excitation/emission wavelength 760/[820 nm 760/[820 nm
Handheld Yes Yes
Pulsed fluorescence imaging No Yes
White-light imaging No Yes
Focus adjustment No Yes
Effective under ambient light conditions No Yes
Pseudocoloring No Yes (green)
Fluorescence image presented in Black and white 1. Black and white
2. Pseudocolored green on a gray-
scaled anatomical background
PDE Photo Dynamic Eye, LED light-emitting diode, CCD charge-coupled device
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TABLE 2 Pre- and intraoperative sentinel node identification findings and pathology results




Average age, years (range) 64.6 (58–74) 54.4 (34–81)
Male/female ratio 5/2 14/6
Tumor type ? tumor stage
SCC, oral cavity 4 2
T1 4 2
Melanoma (head and neck, trunk, or extremity) 3 (1, 1, 1) 13 (10, 1, 2)
Average Breslow thickness, mm (range) 1.6 (1.2–2.1) 2.1 (0.6–4.0)
Ulceration, yes/no 0/3 3/10




Average injected dose, MBq (range) 69.6 (62.1–77.1) 80.6 (67.3–156)
Preoperative number of SNs identified using
SPECT/CT (average, range)
21 (3, 2–5) 51 (2.6, 1–6)
No. of basins (% total), no. of SNs (% total) 16 (100), 21 (100) 40 (100), 51 (100)
Head 1 (6.3), 1 (4.8) 5 (12.5), 6 (11.8)
Auricular – –
Parotid gland – 2 (5.0), 3 (5.9)
Neck (level I–V) 11 (68.8), 15 (71.4) 19 (47.5), 23 (45.1)
Axilla 2 (12.5), 2 (9.5) 2 (5.0), 2 (3.9)
Supraclavicular – 1 (2.5), 1 (2.0)
Scapular 1 (6.3), 1 (4.8) –
Groin 1 (6.3), 2 (9.5) 11 (27.5), 16 (31.4)
Average time injection – operation, hrs (range) 5.5 (4.3–6.5) 6.4 (3.5–19.5)
Intraoperative SN Identification
No. of intraoperatively excised SNs (average,
range)




Specification no. of intraoperative fluorescent SNs (% total) [no. of patients]
Visibility through skin 6 (22.2) [2] 11 (40.7) [4] 26 (35.6) [11]
Per basin:
Head 1 1 1
Auricular – – 1
Parotid gland – – 2
Neck (level I–V) 5 5 17
Axilla – 2 2
Supraclavicular – – –
Scapular – 1 –
Groin – 2 3
Visibility in vivo (prior to excision) 22 (81.4) [6] 27 (100) [7] 75 (100) [20]
Per basin:
Head 1 1 5
Auricular – – 1
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Detection Sensitivity Photo Dynamic Eye (PDE)
Systems
Visual inspection of the fluorescence images generated
by the m-PDE yielded similar detection sensitivities as
reported for the IVIS Spectrum above (1.20 9 10-11 M
ICG–HSA) (Fig. 2b) when fluorescence imaging was per-
formed in the dark or under ambient light conditions
(surrounding lights and plenum turned on) (Fig. 2b). With
all the lights turned on, including the satellite lamps, the
fluorescence detection sensitivity for the m-PDE system
slightly dropped to 2.40 9 10-11 M ICG–HSA.
With the c-PDE system, a detection sensitivity of
3.08 9 10-9 M ICG–HSA was found under dark conditions
(Fig. 2b). This dropped to 4.92 9 10-8 M ICG–HSA when
all the lights in the operating room were turned on (Fig. 2b).
This two-to-three orders of magnitude difference indicates
the m-PDE fluorescence camera system can better cope with
the background light present in an intraoperative setting.
Patient Studies
Conventional PDE Versus Modified PDE Fluorescence
Camera System In the comparison study in seven patients
(oral cavity cancer (n = 4) and melanoma (n = 3)), a total of
27 SNs were harvested (average 3.9, range 2–7) (Table 2).
Initial evaluations performed with the satellite lamps turned
on were of limited success and proved to be highly dependent
on the positioning of the lamps. For that reason, in this
comparison study evaluations were performed with either
the satellite lamps dimmed or with these lights turned on, but
faced away from the surgical wound bed.
With the m-PDE, under ambient light conditions all SNs
evaluated could be easily visualized (100 %). For the c-
PDE, with all lights in the operating room dimmed an
overall detection rate of 81.4 % was found. The m-PDE
system visualized 40.7 % of the SNs transcutaneously (11
SNs, 4 patients; ambient light conditions), while the c-PDE
system visualized only 22.2 % (6 SNs, 2 patients; dimmed
light conditions). In two patients, a lymphatic duct leading
to an SN was visualized with the m-PDE (ambient light
conditions), whereas no lymphatic ducts could be visual-
ized with the c-PDE (dimmed light conditions). Further
detailed results can be found in Table 2.
Electronic supplementary Fig. SI1 presents the surgical
workflow for the c-PDE (Fig. SI1a) and m-PDE (Fig. SI1b)
fluorescence camera system. When using the c-PDE
(Fig. SI1a), lights in the operating room had to be dimmed in
TABLE 2 continued
Direct camera comparison Evaluation of m-PDE
c-PDE m-PDE
Parotid gland – – 8
Neck (level I–V) 19 21 35
Axilla 1 2 2
Supraclavicular – – 4
Scapular 1 1 –
Groin 0 2 18
Visibility lymphatic duct – 2 (7.4) [2] 33 (45.2) [13]
Per basin:
Head – – 2
Auricular – – 1
Parotid gland – – 4
Neck (level I–V) – 2 15
Axilla – – 2
Supraclavicular – – 4
Scapular – – –
Groin – – –
Pathology
No. of tumor-positive SNs (% total) 0/34 4/91 (4.4)
No. of tumor-positive patients (% total) 0/7 4/20 (20.0)
PDE Photo Dynamic Eye, SCC squamous cell carcinoma, MBq mega becquerel, SN sentinel node, SPECT/CT single photon emission computed
tomography combined with computed tomography
a In two patients blue dye was used. Here 2 SNs were excised of which 1 was blue at the time of excision
b In two patients blue dye was used. Here 2 SNs were excised of which were both blue at the time of excision
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Re-excision of the melanoma
scar in patients with
head and neck  melanoma. 
  Re-excision of the melanoma
scar in patients with a melanoma
on the trunk or on an extremity. 
Excision of the
primary tumor in patients
with oral cavity cancer. 
Excision of the primary tumor in 
     patients with penile cancer. 
1. Evaluation of the preoperatively
acquired images. 
2. Blue dye injection. 
3b. Pre-incision gamma tracing to
localize the radioactive signal
emitted by the hybrid tracer. 
3c. Pre-incision near-infrared
fluorescence imaging to evaluate
if the SN(s) can be visualized 
through the skin. 
3a. Pre-incision portable gamma
camera imaging to generate an
overview of the area harbouring
the SN(s). 
In patients with a melanoma of the trunk or 
an extremity, no portable gamma camera 
was used.
No blue dye is used in patients with
head and neck melanoma or oral cavity
cancer.
c-PDE: All lights in the
operation room are dimmed prior to
fluorscence imaging.
m-PDE: Fluorescence imaging is 
performed under ambient light conditions.
The location of the incision was determined
based on the fluorescence signal when
visible through the skin, or on the radio-
active signal received by the gamma probe .
After incision the SN was pursued via gamma
tracing Thereafter alternating attemps were 
mage to visualize the SN via fluorescence 
imaging, and blue dye visualization (if 
applicable) .
If residual radioactivity/remainging fluore-
scence activity was observed at the site of
the excised SN, this was further explored
Addionally excised SNs were considered
part of a cluster of multiple SNs.
After excision of the SN(s) via the in step 
5-6 described approach, the wound bed was 
paplpated for the presence of suspicious 
non-radioactive, non-fluorescent, and/or 
non-blue (if applicable) lymph nodes.
In patients with a melanoma of the turnk or  
an extremity, no portable gamma camera
was used.
4. Incision. 
5. Intraoperative gamma tracing +
near-infrared fluorescence ima-
ging + blue dye visualization. 
6. Sentinel node excision. 
7. Post-excsion wound bed
inspection. 
8. Post-excision portable gamma
camera imaging to confirm
excision of all preoperatively
identified SNs. 
9. Stitching up the SN biopsy
wound. 
FIG. 1 Workflow for sentinel node localization and excision.
Following preoperative image analysis by the surgeon to virtually
determine the location of the SNs (1), blue dye can be injected (2).
Prior to incision a portable gamma camera (Sentinella; Oncovision,
Valencia, Spain), a gamma probe (Neoprobe; Johnson & Johnson
Medical, Hamburg, Germany), and the fluorescence camera (c-PDE
or m-PDE; Hamamatsu Photonics K.K., Hamamatsu, Japan) are use
to determine the location of the SNs (3). After incision (4) the SN is
pursued via gamma tracing, after which alternating attempts were
made to visualize the SN via fluorescence imaging and, when
applicable, blue-dye visualization (5). After identification of the SN,
the node was excised, after which the wound bed was checked for the
presence of residual radioactivity/remaining fluorescence activity at
the site of a previously excised SN. Additionally excised nodes were
considered part of a cluster of multiple adjacent SNs (6). Following
completion of SN biopsy via the combined radio- and fluorescence-
guided (and, when applicable, blue dye) approach, the wound-bed
was palpated for the presence of suspicious non-radioactive, non-
fluorescent and, when applicable, non-blue-dye-stained lymph
nodes (8). Thereafter the wound bed was closed (9). SN sentinel
node, PDE Photo Dynamic Eye
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order to visualize the SNs. This temporarily stalled the sur-
gical procedure. Forceps were often placed at the location of
the SN, after which the lights in the operating room were
turned back on to visually confirm the localization of the SN.
This was followed by SN excision and fluorescence imaging
to confirm removal of the SN. This process was repeated for
each individual SN.
When working with the m-PDE (Fig. SI1b), the pres-
ence of ambient light, presentation of the pseudo-colored
green fluorescence images on a gray-scaled anatomical
background, and the ability to switch the m-PDE to white
light mode, combined, allowed the surgeon to directly
verify the anatomical location of the SNs and proceed with
their excision in a sequential manner. Here, the white light
Normalized fluorescence intensity (a.u) IVIS-Spectrum
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FIG. 2 Determination of the sensitivity of the m-PDE and c-PDE
fluorescence camera systems for ICG–HSA. (a) Fluorescence inten-
sity curve of the various steps of the dilution range measured with the
IVIS Spectrum. (b) Visual fluorescence images obtained with the
IVIS Spectrum, c-PDE, and m-PDE when measured in full darkness,
with all lights in the operating room turned on (satellite lamps,
plenum, and surrounding lights), and with the satellite lamps directly
lighting the sterile field turned off, but the plenum and surrounding
lights on. (c) Light spectrum of the lamps present in the operating
room. The light blue area shows the area in which ICG emits its light.
(d) Absorption and emission spectrum of 1.50 9 10-9 M ICG–HSA.
ICG indocyanine green, HSA human serum albumin, PDE Photo
Dynamic Eye
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FIG. 3 Fluorescence-guided sentinel node excision in a patient with
a melanoma of the neck. (a) Preoperative imaging. Left Static
lymphoscintigram acquired 2 h after hybrid tracer injection showing
only the IS. Middle Following fusion of the acquired SPECT and CT
images, a 3D volume rendering was generated showing the injection
site, as well as an SN in level IV (white arrow) and a supraclavicular
SN. Right Axial fused SPECT/CT (left) and CT (right) slice showing
the SN in level IV being part of a cluster (indicated because no clear
node could be identified on the CT, only a strand of tissue). (b) After
re-excision of the melanoma scar, the SN cluster in level IV was
pursued via fluorescence imaging using the m-PDE fluorescence
camera. The timeline shows fluorescence-guided excision of this
cluster of SNs. Switching between the fluorescence and white light
image allowed the surgeon to work under continuous fluorescence
guidance. A total of three fluorescent (and radioactive) SNs were
removed from the area where the hotspot was seen on SPECT/CT
imaging. IS injection site, SN sentinel node, SPECT/CT single photon
emission computed tomography combined with computed tomogra-
phy, 3D three-dimensional
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mode allowed us to optimally focus the camera. Please see
Fig. 3 for a stepwise illustration on the real-time fluores-
cence-guided excision of three SNs in a cluster under
ambient light conditions. It is interesting to note that even
with the increased detection sensitivity of the m-PDE flu-
orescence camera system, excision of the SNs was not
hindered by background signals as a consequence of
leakage of tracer from damaged lymphatic ducts (Fig. 3).
Extended Clinical Evaluation of Modified PDE
Fluorescence Camera System The m-PDE fluorescence
camera was further evaluated in an additional 20 patients:
oral cavity (n = 2), penile cancer (n = 5), and (head and
neck) melanoma (n = 13). From these patients, 73 SNs
were harvested (average 3.7, range 1–7), of which 35.6 %
(26 SNs; 11 patients) could be visualized transcutaneously
(Table 2). Lymphatic ducts draining from the primary
tumor were identified in 13 patients and 33 SNs (45.2 %)
(Table 2). Transcutaneous SN visualization, as well as
visualization of the lymphatic ducts, was most pronounced
in patients with drainage to SNs in the neck (Table 2).
Examples of our findings are shown in Fig. 3 and
electronic supplementary Figs. SI2 and SI3.
DISCUSSION
In the current study, we evaluated the effect that tech-
nical improvements have on the performance of the
fluorescence camera. For this, the ‘new’ prototype m-PDE
fluorescence camera was evaluated in relation to the ‘old’
c-PDE. After evaluation in a phantom set-up, its value was
defined in patients who were to undergo an SN biopsy
procedure for (head and neck) melanoma, oral cavity, or
urological malignancies using the hybrid tracer
ICG–99mTc-nanocollloid. We have previously reported that
this hybrid tracer, in combination with the m-PDE’s pre-
decessor (the c-PDE), allowed superior optical SN
visualization compared to blue dye in, for example,
patients with vulvar or penile cancer,8,9 or melanoma7 (on
average, 60.7 versus 96.5 %, respectively).
The increased sensitivity of the m-PDE compared with
the c-PDE, as concluded from the phantom studies, trans-
lated nicely in an improved clinical utility of the m-PDE. In
a comparative series of seven patients, the reported two-to-
three orders of magnitude increase in detection sensitivity
resulted in a 14.8 % increase in SN visualization. The
value of the m-PDE fluorescence camera system was fur-
ther underlined in 20 additional patients. With the m-PDE,
35.6 % of the SNs could be visualized transcutaneously
and, for 45.2 % of the SNs, lymphatic ducts were visual-
ized. Its utility was further enhanced by (1) the fact that the
fluorescence image of the m-PDE is corrected real-time for
the influence of ambient light, meaning that the lights in the
operating theatre did not have to be dimmed when per-
forming fluorescence imaging; (2) the ability of the m-PDE
to show the pseudo-colored green fluorescence image on a
gray-scale anatomical background image; and (3) its ability
to directly switch between the fluorescence light and white
light mode. Given the clear clinical potential of this
approach for ICG, which is not a particularly bright dye
with a relatively short luminescence lifetime, this concept
may, in the future, be successfully expanded to other
luminescent tracers that have found their way into the
clinic.10
The technological evolutions realized in the m-PDE help
minimize the disturbance of the clinical workflow and help
to transform fluorescence imaging from a confirmatory
modality to one that provides real-time ‘on-screen’ guid-
ance during SN excision (as illustrated in Fig. 3 and
electronic supplementary Figs. SI1 and SI2). This opti-
mized ‘on-screen’ guidance set-up is comparable to the
type of guidance obtained during (fluorescence-guided)
laparoscopic surgery.4,11 However, during open surgery
procedures, the small overlap of the ICG light spectrum
and the light emitted by the satellite lamp (Fig. 2), in
combination with the high intensity of this light source
(Fig. 2), still meant that the satellite lamps had to be faced
away from the surgical wound bed (or turned off) for
optimal guidance. With the upcoming modernized operat-
ing rooms, in which halogen satellite lamps are exchanged
for LED lamps, this effect will likely become less
prominent.
In the current study, we evaluated the m-PDE in com-
bination with ICG–99mTc-nanocollloid, a hybrid tracer that
was specifically designed as an SN tracer.12,13 The speci-
ficity of this tracer was further confirmed by the minimal
leakage from the lymphatic ducts that we observed with the
m-PDE (Fig. 3). When compared with other studies using
‘free’ ICG where such leakage is more common,11 this
outcome underlines the advantage of using an SN-specific
tracer for SN biopsy procedures. From a technical per-
spective, the advantages the m-PDE has can, in the future,
also provide value in applications for which ‘free’ ICG is
used, e.g. during angiography applications such as free-flap
reconstruction14 or partial nephrectomy,15 for lymphedema
imaging,16 lymphatic mapping11 or the identification of
postoperative lymphatic leaks,17 or the for the identifica-
tion of metastases in the liver.18
CONCLUSION
The m-PDE fluorescence camera system enhances the
fluorescence imaging properties and simplifies the work-
flow compared with its predecessor. We thus think it
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provides a critical next step in the routine use of fluores-
cence-guided surgery.
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